Detalles de la búsqueda
1.
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.
Int J Cancer
; 155(1): 128-138, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447007
2.
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.
Breast Cancer Res
; 25(1): 32, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36978142
3.
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol
; 22(8): 1151-1161, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34252375
4.
Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report.
Int J Hyperthermia
; 37(1): 55-65, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31918587
5.
Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study.
Acta Oncol
; 60(1): 24-27, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33397179
6.
Diagnostic relevance of plasma DNA and DNA integrity for breast cancer.
Tumour Biol
; 35(2): 1183-91, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24018822
7.
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial.
Clin Cancer Res
; 29(22): 4606-4612, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725572
8.
Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivity.
Immunology
; 137(3): 226-38, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23025755
9.
Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial.
JAMA Oncol
; 8(7): 1010-1018, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35588050
10.
Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO.
Clin Breast Cancer
; 20(3): e315-e326, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32273207
11.
Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study.
Front Pharmacol
; 10: 410, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31133847
12.
Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer.
Int J Clin Pharmacol Ther
; 51(1): 59-62, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23260002
13.
Compatibility of Biosimilar Filgrastim with Cytotoxic Chemotherapy during the Treatment of Malignant Diseases (VENICE): A Prospective, Multicenter, Non-Interventional, Longitudinal Study.
Adv Ther
; 33(11): 1983-2000, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27743353
14.
Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy.
Clin Chim Acta
; 425: 206-11, 2013 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23916787
15.
Methods for isolation of cell-free plasma DNA strongly affect DNA yield.
Clin Chim Acta
; 412(23-24): 2085-8, 2011 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21861994
Resultados
1 -
15
de 15
1
Próxima >
>>